Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
First Citizens BancShares, Inc. (NASDAQ: FCNCA) shares surged 42.5% to $829.82 after First-Citizens Bank & Trust Company entered an agreement to purchase all deposits and loans of Silicon Valley Bank.
Alpine Acquisition Corporation (NASDAQ: REVE) surged 32% to $14.17.
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares jumped 30% to $1.93 after gaining 8% on Friday.
Jounce Therapeutics, Inc. (NASDAQ: JNCE) gained 23% to $1.86. Jounce Therapeutics entered into agreement to be acquired by Concentra Biosciences for $1.85 in cash per share plus contingent value rights.
Silvergate Capital Corporation (NYSE: SI) gained 21.5% to $2.09. Silvergate Capital shares jumped 52% on Friday as traders circulated a rumor that a crypto exchange is trying to buy the company's trade processing technologies.
Cimpress plc (NASDAQ: CMPR) jumped 21.4% to $37.91. Truist Securities maintained Cimpress with a Buy and raised the price target from $45 to $50.
Gorilla Technology Group Inc. (NASDAQ: GRRR) surged 20.5% to $9.81.
Pyxis Oncology, Inc. (NASDAQ: PYXS) gained 20.4% to $2.66. Pyxis Oncology recently reported loss of $3.65 per share in FY22.
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) rose 20.2% to $0.5248. Cyclerion Therapeutics received US FDA orphan drug designation for Zagociguat for treatment of mitochondrial diseases.
FG Financial Group, Inc. (NASDAQ: FGF) rose 20% to $2.58 after posting a narrower quarterly loss.
Delcath Systems, Inc. (NASDAQ: DCTH) gained 19.8% to $5.80 after reporting Q4 results. The FDA has accepted the company’s New Drug Application resubmission for HEPZATO Kit (melphalan hydrochloride for injection/hepatic delivery system) seeking approval ...
Benzinga
